AcuityMD today announced that Pristine Surgical has selected its commercial intelligence platform to launch its single-use Summit arthroscope.
Summit, the first technology of its kind, received FDA clearance in January 2023. It combines a 4K disposable arthroscope with the company’s cloud-based Pristine Connect software. According to Pristine Surgical, the endoscope delivers a high-resolution image every time.
The disposable endoscope eliminates the need to purchase expensive equipment and reduces the hidden costs of maintenance contracts and sterilization. Reused endoscopes are often fragile and easily damaged, which negatively affects visualization, disrupts workflows and poses unnecessary safety risks.
According to a press release, Pristine has already begun a limited rollout of Summit. Following this initial launch, the company partnered with AcuityMD to conduct a full rollout in ambulatory surgery centers (ASCs).
AcuityMD’s platform provides streamlined workflows with robust data to help sales teams build comprehensive strategies. The data-driven platform identified which surgeons had the highest arthroscopic volume at ASCs and key opinion leaders, helping to bring Summit to a broader market. This quickly and reliably uncovered key opportunities for Pristine, the companies say.
“AcuityMD has been invaluable in helping us understand which surgeons are performing procedures, where they are being performed, and identifying high-volume regions where we need to specifically hire more reps,” said Dave Carey, Chief Commercial Officer at Pristine Surgical. “The platform’s intuitive interface makes it easy to find detailed data to support tactical outreach and get an overview to help make long-term strategic decisions for market expansion. What would normally require hours or months of research now takes just minutes with a few clicks.”
Pristine plans to use AcuityMD’s platform as an integral part of its sales and marketing efforts across its entire portfolio, with market expansion into the laparoscopy and flexible endoscopy markets planned for 2025. The company plans to use AcuityMD’s platform to familiarize itself with the new markets and develop a smart go-to-market strategy.
“Pristine Surgical is bringing an important medical innovation to market and we are proud to help make their advanced single-use arthroscopes available to as many surgeons as possible,” said Michael Monovoukas, CEO and co-founder of AcuityMD. “We work with six of the top 10 medtech companies and over 200 mid-sized to startup companies and remain committed to accelerating the adoption of these powerful innovations for the benefit of all.”
